If the scientists behind this patent feel that they have invented a more efficacious SSRI treatment, that is good news. Hopefully, the process that follows this patent’s publication -- clinical trials and FDA approval -- will reveal their success, and offer a better solution for those in need of SSRI treatment.
The patent does not explain how or in what ways its pharmaceutical compound improves upon existing SSRIs, nor does it detail what undesirable side effects it avoids. Without further information, it is difficult to judge whether the patent achieves what it claims.
Enjoyed this article? See the latest in our Newsfeed.